Isolation and characterization of antibody fragment selective for human Alzheimer's disease brain-derived tau variants.
Ontology highlight
ABSTRACT: Reagents that can selectively recognize specific toxic tau variants associated with onset and progression of Alzheimer's disease (AD) and other tauopathies can be effective diagnostic and therapeutic tools. We utilized a novel atomic force microscopy-based biopanning protocol to isolate antibody fragments (single chain variable fragments, scFvs) that selectively bind tau variants present in human AD but not cognitively normal age-matched brain tissue. We identified 6 scFvs [Alzheimer's disease tau (ADT)-1 through 6] that readily distinguished between AD and control tissue and sera samples. We utilized 3 of the scFvs (ADT-2, ADT-4, and ADT-6) to analyze longitudinal plasma samples from 50 human patients, 25 patients which converted to AD during the study and 25 that remained cognitively nor
SUBMITTER: Venkataraman L
PROVIDER: S-EPMC7484196 | biostudies-literature | 2020 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA